Centiva Capital, LP Astrazeneca PLC Transaction History

Centiva Capital, LP

$4.79 Billion
Q3 2024

A detailed history of Centiva Capital, LP transactions in Astrazeneca PLC stock. As of the latest transaction made, Centiva Capital, LP holds 7,551 shares of AZN stock, worth $486,586. This represents 0.01% of its overall portfolio holdings.

Number of Shares

7,551

Holding current value

$486,586

% of portfolio

0.01%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$76.67 - $87.62 $578,935 - $661,618	7,551 New	7,551 $588,000
Q4 2023 Feb 14, 2024	BUY	$61.89 - $69.28 $742 - $831	12 Added 1.73%	706 $47,000
Q3 2023 Nov 14, 2023	BUY	$64.85 - $71.7 $45,005 - $49,759	694 New	694 $46,000
Q1 2023 May 15, 2023	BUY	$63.15 - $71.6 $26,207 - $29,713	415 New	415 $28,000
Q2 2022 Aug 15, 2022	SELL	$59.26 - $71.14 $1.43 Million - $1.71 Million	-24,054 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$55.72 - $67.12 $1.34 Million - $1.61 Million	24,054 New	24,054 $1.6 Million
Q3 2021 Nov 15, 2021	SELL	$55.56 - $60.79 $133,066 - $145,592	-2,395 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$48.42 - $60.18 $115,965 - $144,131	2,395 New	2,395 $143,000
Q1 2020 May 15, 2020	SELL	$37.79 - $51.33 $491 - $667	-13 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$42.46 - $50.46 $57,405 - $68,221	-1,352 Reduced 99.05%	13 $1,000
Q3 2019 Nov 13, 2019	BUY	$40.12 - $45.47 $54,763 - $62,066	1,365 New	1,365 $61,000

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

Price T Rowe Associates Inc Baltimore, MD

62.9M
Shares

$4.05 Billion
0.56% of portfolio
Primecap Management CO Pasadena, CA

42M
Shares

$2.71 Billion
2.45% of portfolio
Wellington Management Group LLP Boston, MA

37.2M
Shares

$2.4 Billion
0.52% of portfolio
Capital International Investors Los Angeles, CA

36.8M
Shares

$2.37 Billion
0.57% of portfolio
Franklin Resources Inc San Mateo, CA

19.1M
Shares

$1.23 Billion
0.45% of portfolio

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Centiva Capital, LP with notifications on news.

Account